Effect of Pre-exposure Use of Amantadine on COVID-19 Infection: A Hospital-Based Cohort Study in Patients With Parkinson's Disease or Multiple Sclerosis

Background: Amantadine has been proposed to inhibit E-channel conductance in reconstituted lipid bilayers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We aimed to study whether patients on amantadine have altered risks of contracting COVID-19 infection. Methods: We conducted a ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamel, Walaa A., Kamel, Mohmed I., Alhasawi, Almunther, Elmasry, Sameh, AlHamdan, Fajer, Al-Hashel, Jasem Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529185/
https://www.ncbi.nlm.nih.gov/pubmed/34690911
http://dx.doi.org/10.3389/fneur.2021.704186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529185/
https://www.ncbi.nlm.nih.gov/pubmed/34690911
http://dx.doi.org/10.3389/fneur.2021.704186

Ejemplares similares